SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote (1572)6/3/1998 5:55:00 PM
From: Maurice Winn1 Recommendation  Read Replies (1) of 1762
 
Thanks Don for the url to the European approval of the dodgy drug Rituxan. It was approved half a year ago by the FDA. Why would the Europeans take another half year to approve it? Presumably they have people with NHL who have foregone treatment for that period of time.

The Swiss approved it 2 days after the FDA, so it was in Europe.

The Europeans must have had some serious concerns about Rituxan's efficacy and safety to have stopped it from being sold there for so long. Anyone have any idea what the dangers are? I suspect it was more to the effect that they have a medical guild and many bureaucrats in well paid sinecures and a few hundred dead people don't matter to them - or if they do, then far less than the importance of their paperwork procedures.

Matthew, you favored these approval processes. Would you like to justify the delay? Tell us how many people were saved from their own decisions in co-operation with their advisors and how many died and will die because of delayed Rituxan use in Europe.

Meanwhile, delays in approval for NHL intermediate grade use of adjuvant Rituxan will no doubt continue until the bureaucrats and guild members have taken their share of the profits.

Maurice

[Incidentally, the Techniclone takeover opportunity has faded since its market capitalisation jumped from $15 million when I suggested it to $90 million today. Now THAT would have been a big boost to IDEC's share price. The two companies would be happily synergistic.]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News